Professor Jonathan Emberson
BA, MSc, PhD
Professor of Medical Statistics and Epidemiology
- MRC Population Health Research Unit Programme Leader
- NDPH Deputy Director of Graduate Studies
- MSc in Global Health Science Module Lead: Clinical Trials and Meta-Analysis
Jonathan is Professor of Medical Statistics and Epidemiology within the Nuffield Department of Population Health. After graduating in Mathematics in 1998, he studied statistics and epidemiology at MSc and PhD level before joining the Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU) in 2004.
His main research involves studying the causes and prevention of cardiovascular diseases through the design, conduct and analysis of large-scale observational cohort studies, randomised controlled trials, and individual-participant-data meta-analyses of both types of study. In particular, he is the UK Principal Investigator and MRC Population Health Research Unit (MRC-PHRU) Programme Leader for the Mexico City Prospective Study, a blood-based prospective cohort study of 150,000 Mexican adults followed for more than 15 years.
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
LANDRAY M. et al, (2021), The Lancet
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
The RECOVERY Collaborative Group None. et al, (2021)
Low-intensity daily smoking and cause-specific mortality in Mexico: prospective study of 150 000 adults.
Thomson B. et al, (2021), Int J Epidemiol
Dexamethasone in Hospitalized Patients with Covid-19.
RECOVERY Collaborative Group None. et al, (2021), N Engl J Med, 384, 693 - 704
Abdominal and gluteo-femoral markers of adiposity and risk of vascular-metabolic mortality in a prospective study of 150,000 Mexican adults
GNATIUC L. et al, (2021), European Journal of Preventive Cardiology